Thierry Fumeaux
Hoofd Techniek/Wetenschap/O&O bij Kinarus AG
Profiel
Thierry Fumeaux is currently the Chief Medical Officer at Kinarus AG and Kinarus Therapeutics Holding AG.
He holds a Master's degree in Business Administration from the International Institute for Management Development.
Actieve functies van Thierry Fumeaux
Bedrijven | Functie | Begin |
---|---|---|
Kinarus AG
Kinarus AG Pharmaceuticals: MajorHealth Technology Part of Kinarus Therapeutics Holding AG, Kinarus AG is a Swiss clinical stage pharmaceutical company that focuses on novel treatments to patients suffering from viral, respiratory and ophthalmic diseases. The company is based in Basel, Switzerland. The company was founded in 2017 by Alexander Bausch, Roger Meier. Alexander Bausch has been the CEO since 2017. Kinarus was acquired by Perfect Holding SA on June 03, 2022. | Hoofd Techniek/Wetenschap/O&O | 21-01-2021 |
Eerdere bekende functies van Thierry Fumeaux
Bedrijven | Functie | Einde |
---|---|---|
KINARUS THERAPEUTICS HOLDING AG | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Thierry Fumeaux
International Institute for Management Development | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Kinarus AG
Kinarus AG Pharmaceuticals: MajorHealth Technology Part of Kinarus Therapeutics Holding AG, Kinarus AG is a Swiss clinical stage pharmaceutical company that focuses on novel treatments to patients suffering from viral, respiratory and ophthalmic diseases. The company is based in Basel, Switzerland. The company was founded in 2017 by Alexander Bausch, Roger Meier. Alexander Bausch has been the CEO since 2017. Kinarus was acquired by Perfect Holding SA on June 03, 2022. | Health Technology |
Kinarus Therapeutics Holding AG
Kinarus Therapeutics Holding AG Pharmaceuticals: MajorHealth Technology Curatis Holding AG is a clinical-stage biopharmaceutical company. It engages in the business of discovering and developing novel therapeutics for the treatment of viral, respiratory, and ophthalmic diseases. The company was founded on April 8, 1997 and is headquartered in Basel, Switzerland. | Health Technology |